Evidence map›Paper›PMID 32340321›Full record

ReviewDiagnostics (Basel, Switzerland)2020

Dried Blood Spot in Laboratory: Directions and Prospects.

Kristina Malsagova, Artur Kopylov, Alexander Stepanov, Tatyana Butkova, Alexander Izotov, Anna Kaysheva

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Detection of AdenoviralInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kristina MalsagovaInstitute of Biomedical Chemistry, Biobanking Group, Moscow 109028, Russia.
Artur KopylovInstitute of Biomedical Chemistry, Biobanking Group, Moscow 109028, Russia.ORCID 0000-0002-7199-372X
Alexander StepanovInstitute of Biomedical Chemistry, Biobanking Group, Moscow 109028, Russia.ORCID 0000-0002-9113-9440
Tatyana ButkovaInstitute of Biomedical Chemistry, Biobanking Group, Moscow 109028, Russia.ORCID 0000-0001-5111-3863
Alexander IzotovInstitute of Biomedical Chemistry, Biobanking Group, Moscow 109028, Russia.
Anna KayshevaInstitute of Biomedical Chemistry, Biobanking Group, Moscow 109028, Russia.ORCID 0000-0003-4472-2016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few years, dried blood spot (DBS) technology has become a convenient tool in both qualitative and quantitative biological analysis. DBS technology consists of a membrane carrier (MC) on the surface of which a biomaterial sample becomes absorbed. Modern analytical, immunological or genomic methods can be employed for analysis after drying the sample. DBS has been described as the most appropriate method for biomaterial sampling due to specific associated inherent advantages, including the small volumes of biomaterials required, the absence of a need for special conditions for samples' storage and transportation, improved stability of analytes and reduced risk of infection resulting from contaminated samples. This review illustrates information on the current state of DBS technology, which can be useful and helpful for biomedical researchers. The prospects of using this technology to assess the metabolomic profile, assessment, diagnosis of communicable diseases are demonstrated.

Indexed as

dried blood spots (DBS)ELISAMSpostgenomic technologiesserodiagnosis

Identifiers

PMID32340321
PMCPMC7235996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.